Get started
Author

Quynh Lam

Observed name: Quynh T. Lam
OpenAlex ID: A5002881895
BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications
2011 · Dora Dias-Santagata, Quynh Lam, et al. · PLoS ONE · 315
PDF
Activation of PI3K Signaling in Merkel Cell Carcinoma
2012 · Valentina Nardi, Youngchul Song, et al. · Clinical Cancer Research · 113
PDF
Low saliva pH can yield false positives results in simple RT-LAMP-based SARS-CoV-2 diagnostic tests
2021 · Cristina Uribe-Alvarez, Quynh Lam, et al. · PLoS ONE · 58
PDF
Case study of CD19 CAR T therapy in a subject with immune-mediate necrotizing myopathy treated in the RESET-Myositis phase I/II trial
2024 · Jenell Volkov, Daniel Nunez, et al. · Molecular Therapy · 54
A potential role for targeted therapy in a subset of metastasizing adnexal carcinomas
2011 · Dora Dias-Santagata, Quynh Lam, et al. · Modern Pathology · 46
PDF
Malignant Neurocristic Hamartoma
2011 · Katy R. Linskey, Dora Dias-Santagata, et al. · The American Journal of Surgical Pathology · 34
Genomic and immunohistochemical analysis in human adrenal cortical neoplasia reveal beta-catenin mutations as potential prognostic biomarker
2015 · Alexandra E. Kovach, Carmelo Nucera, et al. · Discoveries · 7
PDF
Case study of resecabtagene autoleucel in a subject with diffuse cutaneous systemic sclerosis treated in the RESET-SSc trial
2025 · Daniel Nunez, Jenell R. Volkov, et al. · Molecular Therapy Advances · 2
Reset Sle: Clinical Trial Evaluating Caba-201, a Fully Human, Autologous 4-1bb Anti-cd19 Car T Cell Therapy in Nonrenal Sle and Lupus Nephritis
2025 · Saira Sheikh, Vimal Derebail, et al. · The Journal of Rheumatology · 2
An Enhanced Recovery After Surgery Protocol Decreases the Use of Post Bypass Narcotics
2021 · Lili Sadri, Deepak Shan, et al. · Journal of Vascular Surgery · 1
Mechanistic basis of the acute safety profile of rese-cel, an autologous CD19-CAR T, in patients with autoimmune disease treated in four ongoing phase 1/2 clinical trials
2025 · Daniel Nunez, Jenell Volkov, et al. · Blood
Supplementary Table 4 from Activation of PI3K Signaling in Merkel Cell Carcinoma
2023 · Valentina Nardi, Youngchul Song, et al.
Supplementary Table 3 from Activation of PI3K Signaling in Merkel Cell Carcinoma
2023 · Valentina Nardi, Youngchul Song, et al.
Supplementary Table 1 from Activation of PI3K Signaling in Merkel Cell Carcinoma
2023 · Valentina Nardi, Youngchul Song, et al.
Data from Activation of PI3K Signaling in Merkel Cell Carcinoma
2023 · Valentina Nardi, Youngchul Song, et al.
Data from Activation of PI3K Signaling in Merkel Cell Carcinoma
2023 · Valentina Nardi, Youngchul Song, et al.
Supplementary Table 2 from Activation of PI3K Signaling in Merkel Cell Carcinoma
2023 · Valentina Nardi, Youngchul Song, et al.
PDF
Supplementary Table 3 from Activation of PI3K Signaling in Merkel Cell Carcinoma
2023 · Valentina Nardi, Youngchul Song, et al.
PDF
Supplementary Table 4 from Activation of PI3K Signaling in Merkel Cell Carcinoma
2023 · Valentina Nardi, Youngchul Song, et al.
PDF
Supplementary Table 1 from Activation of PI3K Signaling in Merkel Cell Carcinoma
2023 · Valentina Nardi, Youngchul Song, et al.
PDF
Supplementary Table 2 from Activation of PI3K Signaling in Merkel Cell Carcinoma
2023 · Valentina Nardi, Youngchul Song, et al.
Abstract 2210: Activation of PI3K in Merkel cell carcinoma
2011 · Valentina Nardi, Young Chul Song, et al. · Cancer Research
Works count: 22
Citation count: 632
H-index: 7
I10-index: 6
Year
Topic
Type